DA

Dianne Angus

Cyclopharm Limited | Non-Executive Director
Ms Angus has executive managerial and company director experience in the biotechnology, biopharmaceutical, medical device, agritech and healthcare industries. Dianne has created global industry partnerships to yield medical, pharmaceutical and agricultural products. She has also driven the development path for novel neurological pre-clinical agents to late stage clinical assets before the FDA and European regulators. With over twenty five year' experience in ASX and NASDAQ listed companies, she has experience in business development, capital raising and investor relations together with corporate governance and compliance capabilities. She is also a council member of Deakin University.

Companies and Roles

Company
Title
Tenure
Since
CYC
Cyclopharm Limited
  • Non-Executive Director
3yrs, 10mthAug 2021
AGN
Argenica Therapeutics Limited
  • Non-Executive Director
1yrs, 6mthDec 2023
NEU
Neuren Pharmaceuticals Limited
  • Non-Executive Director
6yrs, 11mthJul 2018

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
NEU
Neuren Pharmaceuticals Limited
14/03/2530,000N/AN/AN/A
CYC
Cyclopharm Limited
30/12/2422,323N/AN/AN/A
AGN
Argenica Therapeutics Limited
28/08/24N/AN/A500,000N/A
21/04/23323,375N/A500,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
AGN
Argenica Therapeutics Limited
14/08/24
Issued
500,000$0.275$137,727Issue of options
CYC
Cyclopharm Limited
28/06/24
Issued
12,323$1.420$17,500Participation in share purchase plan
21/04/23
Issued
50,000$0.017$850As advised by the company
21/04/23
Issued
30,375$0.017$516Rights issue
CYC
Cyclopharm Limited
29/11/22
Buy
1,254$1.300$1,630On-market trade